# KYGEVVI

NDC: 50474-350
Generic name: doxecitine and doxribtimine
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20260301

FDA application: NDA219792

## Active ingredients

- DOXECITINE: 2 g/1
- DOXRIBTIMINE: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-350"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-350
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d5ce670-9314-4fd7-8b0a-1447910dcf9e